One of the great misconceptions in wound care is that a wound heals best when permitted to form a dry scab. By contrast, moisture has repeatedly been shown to significantly accelerate wound healing.
Emergency physicians and other acute care providers are encouraged to incorporate occlusive (closing a wound and keeping it from air) moisture-retentive dressings into their regular practice to expedite healing, reduce pain and scarring, improve wound care convenience and patient compliance, and minimise wound contamination and infection.
CryoSlices has identified a gap in the market and is currently developing a Class 11 medical device for the application of the technology for chronic and acute wounds.
The formula for sodium hypochlorite is NaOCI & the formula for hypochlorous acid is HOCI. Hypochlorous acid is the same substance your white blood cells produce to the fight infection. And it’s so gentle it’s used in wound healing products. When the pH of bleach is lowered (made acidic) the hypochlorite converts to hypochlorous. Bleach is defined as 1)having a pH of 11; and 2) being at a concentration high enough to remove colour from fabric and 3) 99%+ NaOCI; none of these apply to hypochlorous acid. An interesting fact is that you need a lot more bleach to achieve the same anti-microbial power as hypochalorous acid.
An electrical charge is passed through a salt (NaCI) solution, where the sodium separates from the chloride. Chloride is negatively charged and is attracted to the positive side of the electrical charge where it bonds with oxygen and hydrogen from the water. Is gets converted from CI- to HOCI, otherwise known as Hypochlorous acid, the active ingredient in our products. Hypochlorous acid is so gentle and effective it’s commonly used in wound healing products (FDA approved) and other healthcare products. The sodium is positive and is thus attracted to the negative charge, where it also bonds with oxygen and hydrogen and is electrochemically converted to sodium hydroxide or NaOH.
Overall it is estimated that 15% of patients will suffer from diabetic foot ulceration during their lifetime. Diabetes accounts for around 10% of the annual NHS budget. People with diabetes are more likely to be admitted to hospital with a foot ulcer than with any other complication of diabetes. Foot ulcers and amputations account for around £1 in every £150 the NHS spends each year. A number of studies have demonstrated that proper management of diabetic foot ulcers can greatly reduce, delay or prevent complications such as infection, amputation, gangrene, and even death.
It is with passion and determination that we are innovating for this segment of the market. Our cryoSlices® patches, are a new innovation currently in development and consists of a unique & successful combination of our patented cryoGel dermal delivery system (a solid, stable, long lasting gel patch) with HOCL (an FDA approved ingredient that is usually only stable in liquid form, and proven successful in the wound care industry) to create an Emergency Care & @Home Treatment for patients with acute and chronic wounds such as surgical wounds, burns, diabetic ulcers, bed sores, non & slow healing wounds, as well as dermal infections. We are working with the below organisations to register a Class 11 medical device.
The future is about collaboration and we would love to hear from you if you are in research, clinical trials, medical professionals with an interest in wound care or infection control, funders in medicare and would like to get involved in our projects.
“If you want to go fast, go alone. If you want to go far, go together”
– An African Proverb
Ask a question/stock our product/become a distributor/send us feedback.
Fill in our contact form to organise a call or meeting and have your first introduction to the cryoSlices® products.
Speak to one of our experts today:
Contact Details: South Africa
Contact Details: UK
We are meaning makers who through inspiration, innovation and unwavering resolve, innovate globally unique brands at affordable prices in order to create disruptive innovations.
